Search

everythinglearnresearchcommunity

for

Search:↓

TLR7-based compounds may help manage chemotherapy-induced hair loss.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Cholesterol issues in skin and hair may cause permanent hair loss by triggering inflammation.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Short-chain fatty acids from *Cutibacterium acnes* cause skin inflammation, contributing to acne.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Alkaloids help fight influenza in animals but need more research for human use.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

ALA-photodynamic therapy helps reduce acne by causing acne cell death and lowering certain skin protein levels.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Human skin cells produce proenkephalin, which changes with environmental factors and skin diseases.

BeauTop helps hair grow by increasing certain growth factors.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Disrupted cholesterol production impairs hair follicle stem cells, leading to hair loss.

We now understand more about what causes acne and this could lead to better, more personalized treatments.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Oxidized LDL reduces cell growth but affects stem cell differentiation less negatively than cytokine-induced inflammation.

Imiquimod 5% cream reduced equine sarcoids in most cases.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.